Home |
Free Dividend Report |
Stock Splits Calendar |
RXII Historical Stock Prices |
Preferred Stock Newsletter |
RXII Options Chain |
Stock Message Boards |
RXII (RXII) has the following price history information. Looking back at RXII historical stock prices for the last five trading days, on November 12, 2018, RXII opened at $0.41, traded as high as $0.41 and as low as $0.33, and closed at $0.35. Trading volume was a total of 4.80M shares. On November 13, 2018, RXII opened at $0.34, traded as high as $0.36 and as low as $0.34, and closed at $0.35. Trading volume was a total of 824.20K shares. On November 14, 2018, RXII opened at $0.38, traded as high as $0.39 and as low as $0.31, and closed at $0.33. Trading volume was a total of 2.94M shares. On November 15, 2018, RXII opened at $0.32, traded as high as $0.34 and as low as $0.31, and closed at $0.33. Trading volume was a total of 948.00K shares. On November 16, 2018, RXII opened at $0.33, traded as high as $0.33 and as low as $0.32, and closed at $0.33. Trading volume was a total of 461.20K shares.
RXII Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into RXII shares, starting with a $10,000 purchase of RXII, and working forward through the historical stock price information to today.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 04/28/2014 | |
End date: | 11/16/2018 | |
Start price/share: | $359.00 | |
End price/share: | $0.33 | |
Dividends collected/share: | $0.00 | |
Total return: | -99.91% | |
Average Annual Total Return: | -78.45% | |
Starting investment: | $10,000.00 | |
Ending investment: | $9.18 | |
Years: | 4.56 |
RXII Historical Price Range | |||||
Date | Open | High | Low | Close | Volume |
11/12/2018 | $0.41 | $0.41 | $0.33 | $0.35 | 4.80M |
11/13/2018 | $0.34 | $0.36 | $0.34 | $0.35 | 824.20K |
11/14/2018 | $0.38 | $0.39 | $0.31 | $0.33 | 2.94M |
11/15/2018 | $0.32 | $0.34 | $0.31 | $0.33 | 948.00K |
11/16/2018 | $0.33 | $0.33 | $0.32 | $0.33 | 461.20K |
About RXII |
RXi Pharmaceuticals is a clinical-stage company developing therapeutics based on its self-delivering RNAi (sd-rxRNA®) platform and Samcyprone, a topical immunomodulator. Co.'s clinical development programs include RXI-109, an sd-rxRNA for the treatment of dermal and ocular scarring, and Samcyprone, for the treatment of warts. Co.'s development programs also include cell-based cancer immunotherapy. Co.'s RNAi therapies are designed to silence, or down-regulate, the expression of a specific gene that may be over-expressed in a disease condition and its topical immunotherapy agent, Samcyprone, treats diseases by inducing, enhancing or suppressing an immune response in the skin. |
RXII Historical Closing Prices | |
Date | Close |
11/12/2018 | $0.35 |
11/13/2018 | $0.35 |
11/14/2018 | $0.33 |
11/15/2018 | $0.33 |
11/16/2018 | $0.33 |
Healthcare Historical Prices |
RXII is categorized under the Healthcare sector; below are some other companies in the same sector:
RYTM Historical Stock Prices Also explore: RXII shares outstanding history
Free RXII Email Alerts:
|
RXII Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.